AOD-9604 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-31 and is reviewed periodically as new material appears.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
== Medical and recreational use == Prescription of dipipanone is discouraged apart from in exceptional circumstances, because of the perceived risk of abuse — the BNF marks the substance as "less suitable for prescribing" along with other older compounds such as pethidine and pentazocine with unusual abuse patterns. The combination with cyclizine leads to a very strong "rush" if the drug is injected, however the tablets contain insoluble binders which can lead to serious injury or death. During the late 1970s to early 1980s in the UK, many deaths were blamed on misuse of this preparation. As supplies became unavailable, opiate users would mix crushed methadone tablets with crushed cyclizine tablets, in an attempt to replicate the effect of Diconal. When taken orally as indicated for pain, the risk of addiction and euphoric potential is similar to that of morphine, The historical deaths linked to misuse of this drug may make this drug distasteful for prescribing doctors.
=== Pharmacokinetics === The elimination half-lives of clinically used orexin receptor antagonists are 12 hours for suvorexant, about 17 to 19 hours ("effective" half-life) or 55 hours (terminal elimination half-life) for lemborexant, and 6 to 10 hours for daridorexant. The elimination half-lives of investigational orexin receptor antagonists are 2 to 3 hours for seltorexant and about 1.5 to 3 hours for vornorexant. The pharmacokinetics of suvorexant are significantly affected by age, sex, and other factors, leading to increased blood concentrations in female, obese, and older patients. These factors do not significantly affect the pharmacokinetics of lemborexant or daridorexant. All three marketed orexin antagonists do not need to be dose adjusted in patients with reduced renal function, as the pharmacokinetic profiles of these medications are not significantly affected. In patients with moderate to severe hepatic impairment, dose adjustments of these medications may be necessary.
seconds). In vacuum technology, the residence time of gases on the surfaces of a vacuum chamber can determine the pressure due to outgassing. If the chamber can be heated, the above equation shows that the gases can be "baked out"; but if not, then surfaces with a low residence time are needed to achieve ultra-high vacuums.
Jack Straw (born 3 August 1946), Christian, of Eastern European Jewish ancestry; served in Cabinet under Labour governments of Tony Blair and Gordon Brown as Home Secretary and Foreign Secretary; has written for The Guardian, Daily Mail, El País, The Independent, The Mirror UK, The Sun, The Telegraph, Financial Times, The Times, POLITICO, LSE Connect, Prospect Magazine, The New European and is author or co-author of the following books; The English Job: Understanding Iran and Why It Distrusts Britain (2019) ISBN 978-1785903991; Implementation of the Human Rights Act 1998: Minutes of Evidence, Wednesday 14 March 2001 (2001) ISBN 0-10-442701-9; Making Prisons Work: Prison Reform Trust Annual Lecture (1998) ISBN 0-946209-44-8; Future of Policing and Criminal Justice (Institute of Police & Criminological Studies Occasional Paper S.) (1996) ISBN 1-86137-087-3 and Policy and Ideology (1993) ISBN 0-9521163-0-8 John Strawson, author of Encountering Islamic law, Partitioning Palestine: Legal Fundamentalism in the Palestinian-Israeli Conflict and editor of Law after Ground Zero and Tracking the Postcolonial in Law; also law professor at the University of East London School of Law, teaching International law and Middle East Studies; specialises in law and postcolonialism, with particular reference to middle east, Islam and international law; previous posts include visiting positions at Birzeit University (Palestine) and the Institute of Social Studies (The Hague Netherlands); researches encounter between western and Islamic law; is Director of Law Postgraduate Programmes at University of East London, and Director of the Centre on Human Rights in Conflict; believes use of term apartheid to describe Israel or Israeli policies does not apply to Israel, and use of analogy is unhistorical, and unhelpful. Jamie Susskind (b. 1989); barrister and author of Oxford University Press books on Marxism, freedoms, democracy and technology; was appointed as a research fellow at Harvard's Berkman Klein Center for Internet and Society; practises law at Littleton Chambers; his book Future Politics: Living Together in a World Transformed by Tech, listed by London School of Economics as one of top ten books of 2019; book approaches issues of technological change in political arena from legal standpoint, speculating on various ways technology would change interactions between citizens and political process; was awarded Book of the Year by Evening Standard and Prospect Magazine, Book of the Day by The Guardian and received the 2019 Estoril Global Issues Distinguished Book Prize; his book, The Digital Republic: On Freedom and Democracy in the 21st Century concerns dangers, problems, and solutions to Big Tech. Richard Susskind OBE FRSE (born 28 March 1961); author, speaker, independent adviser to international professional firms and national governments; IT adviser to Lord Chief Justice of England and Wales, holds professorships at the University of Oxford, Gresham College and Strathclyde University, is a past chair of Advisory Panel on Public Sector Information, and is president of the Society for Computers and Law; has authored nine books and is regular columnist at The Times. Adam Sutcliffe; Professor of European History at King's College London, journalist writing on Jewish history and identity for Times Literary Supplement, author of What Are Jews For: History, Peoplehood, and Purpose (Princeton University Press, 2020), Judaism and Enlightenment; coeditor of Philosemitism in History, The Cambridge History of Judaism: The Early Modern World, and History, Memory and Public Life: The Past in the Present. William Sutcliffe, novelist; New Boy (1986), Are You Experienced? (1997), Whatever Makes You Happy (2008), and The Wall (2013), set in an Israeli colony David Sylvester (21 September 1924 – 19 June 2001), prolific author, art critic, journalist and curator; trustee of the Tate Gallery; influential in promoting modern artists Francis Bacon, Joan Miró, and Lucian Freud; father of modern artist Cecily Brown; credited with coining the term Kitchen sink realism originally to describe a strand of post-war British painting. Mitchell Symons, writer Henri Tajfel (born Hersz Mordche; 22 June 1919 – 3 May 1982) was a Polish Jewish social psychologist and author, best known for his books and pioneering work on the cognitive aspects of prejudice and social identity theory, as well as being one of the founders of the European Association of Experimental Social Psychology. He also worked for the United Nations International Refugee Organization. Adam Thirlwell, FRSL (born 22 August 1978) is a British novelist. His work has been translated into thirty languages. He has twice been named as one of Granta's Best of Young British Novelists. In 2015 he received the E.M. Forster Award from the American Academy of Arts and Letters. He is an advisory editor of The Paris Review. Barbara Trapido (born 1941 as Barbara Schuddeboom), is a British novelist born in South Africa with German, Danish and Dutch ancestry. Born in Cape Town and growing up in Durban she studied at the University of Natal gaining a BA in 1963 before emigrating to London. After many years teaching, she became a full-time writer in 1970. Michael Tugendhat (born 21 October 1944),; retired High Court judge; was High Court's senior media judge; author and editor of The Law of Privacy and the Media Oxford University Press; Commercial Fraud: Civil Liability, Human Rights, and Money Laundering Oxford University Press; Les droits du genre humain : la liberté en France et en Angleterre (1159–1793), [The rights of mankind : liberty in France and England (1159–1793)] (with Elizabeth de Montlaur Martin, 2021), ISBN 978-2-36517-110-6, Société de Législation comparée, Paris (awarded by the French Académie des sciences morales et politiques the Prix Édouard Bonnefous 2022); Liberty Intact: Human Rights in English Law (2016) Oxford University Press and Fighting for Freedom? (2017), ISBN 978-1-911128-49-6, Bright Blue (organisation) Jackie Walker (activist), anti Zionist playwright, pro-Palestinian, anti fascist author, of Sephardi Jewish and Jamaican origin. Arthur Waley (1889–1966); orientalist and sinologist of Ashkenazi ancestry; renowned for his translations of Chinese and Japanese poetry; awarded the CBE in 1952, the Queen's Gold Medal for Poetry; invested as a Companion of Honour in 1956. Natasha Walter (born 20 January 1967), feminist writer, novelist, human rights activist, founder of charity Women for Refugee Women; father was Nicolas Walter, an anarchist and secular humanist writer; of German Jewish ancestry; journalist forVogue magazine; Deputy Literary Editor of The Independent; columnist and feature writer for The Guardian; appear regularly on BBC2's Newsnight Review and Radio 4's Front Row; was judge on the Booker Prize and was a judge on the Women's Prize for Fiction (formerly the Orange Prize); was the founder in 2006 of the charity Women for Refugee Women, where she was the director until 2021. The charity supports women who seek asylum to tell their stories and challenges injustices they experience. She was recognized as one of the BBC's 100 women of 2013. Nicolas Walter (22 November 1934 – 7 March 2000) was a British anarchist and atheist writer, speaker and activist. He was a member of the Committee of 100 and Spies for Peace, and wrote on topics of anarchism and humanism. Fredric Warburg (27 November 1898 – 25 May 1981), author, publicist, publisher best known for association with George Orwell. Besides his own work as an author, he promoted and published Franz Kafka. Other notable publications included The Third Eye by Lobsang Rampa, Adolf Hitler's Mein Kampf and William Shirer's The Rise and Fall of the Third Reich. Ruby Wax (née Wachs; born 19 April 1953) is an American-British actress, author of popular self-help books, comedian, television personality, and popular mental health campaigner, of Austrian Jewish descent; appointed Chancellor of the University of Southampton; Wax also teaches business communication in the public and private sectors. Clients include Deutsche Bank, the UK Home Office and Skype. Eyal Weizman (born 1970) is a British Israeli architect and author of over twenty books and academic papers, mostly on the Israeli occupation of Palestinian land and the architecture of the wall around Gaza. He is the director of the research agency Forensic Architecture at Goldsmiths, University of London where he is Professor of Spatial and Visual Cultures and a founding director there of the Centre for Research Architecture at the department of Visual Cultures. In 2019 he was elected Fellow of the British Academy. Rosie Whitehouse, journalist and author. Wife of Tim Judah and mother of Ben Judah; of Iraqi Jewish ancestry. Her historical research and profiles of Holocaust Survivors have been published by The Observer, The Jewish Chronicle, BBC News and Tablet magazine. Meanwhile, her writing about British government policy toward victims after the Holocaust and contemporary British antisemitism has appeared in The Independent and Haaretz. Stephen Winsten, (1893–1991) was the name adopted by Samuel Weinstein, one of the 'Whitechapel Boys' group of young Jewish men and future writers in London's East End in the years before World War I (the others included Isaac Rosenberg, John Rodker and Joseph Leftwich). In the First World War he was a conscientious objector, and imprisoned in Bedford and Reading gaols. He is now known for his works about George Bernard Shaw, and his writing on the life of Henry Salt. Robert Winston, Baron Winston (born 15 July 1940), British professor, author, journalist, medical doctor, scientist, television presenter and Labour Party politician.He is a member of Labour Friends of Israel; father of Ben Winston, renowned for producing a number of the annual Brit Awards from 2011 to 2014 and more recently he was a co-producer of US Grammy Awards and Tony Awards. Ludwig Wittgenstein (26 April 1889 – 29 April 1951) was an Austrian-Jewish British philosopher who worked primarily in logic, the philosophy of mathematics, the philosophy of mind, and the philosophy of language. He is considered by some to be the greatest philosopher of the 20th century. Richard Wollheim (5 May 1923 − 4 November 2003), prolific author noted for work on mind and emotions related to visual arts, specifically, painting; served as president of the British Society of Aesthetics; was Grote Professor of Mind and Logic, professor at Columbia University and University of California at Berkeley and lecturer at Balliol College, Harvard University, the University of Minnesota, Graduate Center, CUNY, the University of California at Davis; gave Andrew M. Mellon lectures in Fine Arts, National Gallery of Art, Washington; his book Art and its Objects considered one of the twentieth century's most influential texts on philosophical aesthetics; known for philosophical treatments of depth psychology, especially Sigmund Freud's Jonathan Wolff (born 1959) author of seven Oxford University Press academic books and numerous monographs and journals, philosopher and scholar; Professor of Values and Public Policy at the Blavatnik School of Government at the University of Oxford; Governing Body Fellow at Wolfson College; previously at University College London (UCL), where he was Professor of Philosophy and Dean of the Faculty of Arts and Humanities; was secretary of the British Philosophical Association and has been Editor and honorary secretary of the Aristotelian Society; presented a four-part series about the UK's National Health Service (NHS) for the BBC's Radio 3; was member of the Nuffield Council on Bioethics; was elected Fellow of the British Academy in 2023. Leonard Woolf, writer and activist Bat Ye'or (born 1933), best known for creating and popularising Eurabia conspiracy theory in her writings about modern Europe. Tamar Yellin (b. 1963), author whose first novel, The Genizah at the House of Shepher, won Sami Rohr Prize for Jewish Literature; granddaughter of Yitzhak Yaakov Yellin (1885–1964), pioneer of Hebrew language press in Palestine; Jane Yolen (February 11, 1939) is an American writer of fantasy and part-time resident in the UK, science fiction, and children's books. She is the author or editor of more than 400 books, of which the best known is The Devil's Arithmetic, a Holocaust novella Israel Zangwill (1864–1926), novelist and playwright. Zangwill was a British author at the forefront of cultural Zionism during the 19th century, and was associate of Theodor Herzl, later rejecting search for a Jewish homeland in Palestine. Father of Oliver Zangwill and husband of Suffragette Edith Ayrton. Theodore Zeldin, writer
Sources: en.wikipedia.org
Individual quick freezing is a descriptive term that includes all forms of freezing that is "individual" (not in a whole block) and "quick" (taking a maximum of several minutes). It may correspond to cryogenic freezing, fluidized bed freezing, or any other technique that meets the definition.
Tofu skin is produced when soy milk is boiled in an open, shallow pan, thus producing a film or skin composed primarily of a soy protein-lipid complex on the liquid surface. Tofu skin is cooked with noodles.
== Natural history == Although it is generally accepted that vanilla was domesticated in Mesoamerica and subsequently spread to the Old World in the 16th century, in 2019, researchers published a paper stating that vanillin residue had been discovered inside jars within a tomb in Canaan dating to the 2nd millennium BCE, suggesting the possible cultivation of an unidentified, Old World-endemic Vanilla species in Canaan since the Middle Bronze Age. Traces of vanillin were also found in wine jars in Jerusalem, which were used by the Judahite elite before the city was destroyed in 586 BCE. Vanilla beans, called tlilxochitl, were discovered and cultivated as a flavoring for beverages by native Mesoamerican peoples, most famously the Totonacs of modern-day Veracruz, Mexico. Since at least the early 15th century, the Aztecs used vanilla as a flavoring for chocolate in drinks called xocohotl.
Sources: en.wikipedia.org
Unlike most modern eggs, many non-avian dinosaur eggs had a rough texture formed by nodes and ridges ornamenting the surface of their shell. This is predominant in Cretaceous dinosaur eggs, but very rare in eggs from the Jurassic or Triassic. Because of the lack of modern analogues, the purpose of eggshell ornamentation is unknown, but many functions have been proposed. Possibly, they provided extra strength to the eggshell without having pore canals too long for adequate gas exchange. They could also have helped keep substrate away from the pore openings of eggs that were buried, but modern turtles and crocodylians which bury their eggs have smooth eggshells, so this adaptation is not necessary for animals which bury their eggs. Another hypothesis, proposed by R. M. Mellon in 1982 in his senior thesis at Princeton University, is that the ridges and nodes would have formed pathways for gas to flow across the surface of the eggshell, preventing accumulation of too much CO2 and aiding the flow of oxygen and water vapor. Since it varies from egg to egg, the texture of an eggshell's ornamentation is useful for classification. Six types of ornamentation were catalogued by Carpenter in 1999:
In the first step shown, an aldehyde derived from phenylalanine is treated with zinc dust in the presence of vanadium(III) chloride. This results in a pinacol coupling reaction which dimerizes the material to provide an intermediate which is converted to its epoxide and then reduced to (2S,3S,5S)-2,5-diamino-1,6-diphenylhexan-3-ol. Importantly, this retains the absolute stereochemistry of the amino acid precursor. The diamine is then treated sequentially with two thiazole derivatives, each linked by an amide bond, to provide ritonavir.
In 1933, Fermi published his landmark theory for beta decay, where he applied the principles of quantum mechanics to matter particles, supposing that they can be created and annihilated, just as the light quanta in atomic transitions. Thus, according to Fermi, neutrinos are created in the beta-decay process, rather than contained in the nucleus; the same happens to electrons. The neutrino interaction with matter was so weak that detecting it proved a severe experimental challenge. Further indirect evidence of the existence of the neutrino was obtained by observing the recoil of nuclei that emitted such a particle after absorbing an electron. Neutrinos were finally detected directly in 1956 by the American physicists Clyde Cowan and Frederick Reines in the Cowan–Reines neutrino experiment. The properties of neutrinos were (with a few minor modifications) as predicted by Pauli and Fermi.
==== Cross-linking and phosphorylation ==== Allergen-mediated FcεR1 cross-linking signals are very similar to the signaling event resulting in antigen binding to lymphocytes. The Lyn tyrosine kinase is associated with the cytoplasmic end of the FcεR1 β chain. The antigen cross-links the FcεR1 molecules, and Lyn tyrosine kinase phosphorylates the ITAMs in the FcεR1 β and γ chain in the cytoplasm. Upon the phosphorylation, the Syk tyrosine kinase gets recruited to the ITAMs located on the γ chains. This causes activation of the Syk tyrosine kinase, causing it to phosphorylate. Syk functions as a signal amplifying kinase activity due to the fact that it targets multiple proteins and causes their activation. This antigen stimulated phosphorylation causes the activation of other proteins in the FcεR1-mediated signaling cascade.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.